Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein
- 1 June 1999
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 169 (1) , 147-159
- https://doi.org/10.1111/j.1600-065x.1999.tb01313.x
Abstract
Summary: T‐cell receptor (TCR) transgenic mice provide the ability to follow the maturation and fate of T cells specific for self‐antigens in vivo. This technology represents a major breakthrough in the study of autoimmune diseases in which specific antigens have been implicated. Proteins expressed within the central nervous system are believed to be important autoantigens in multiple sclerosis, TCR transgenic models specific for myelin basic protein (MBP) allowed us to assess the role of tolerance in providing protection from T cells with this specificity Our studies demonstrate that T cells specific for the immunodominant epitope of MBP do not undergo tolerance in vivo and that TCR transgenic mice are susceptible to spontaneous autoimmune disease. The susceptibility to spontaneous disease is dependent on exposure to microbial antigens, MBP TCR transgenic models expressing TCRs specific for the same epitope of MBP but utilizing different Vα genes exhibit differing susceptibilities to, spontaneous disease. These data support the idea that genetic and environmental differences play a role in susceptibility to autoimmunity MBP TCR transgenic models are playing an important role in defining mechanisms by which infectious agents trigger autoimmune disease as well as defining mechanisms by which tolerance is induced to distinct epitopes within self‐antigens.Keywords
This publication has 111 references indexed in Scilit:
- Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the DiseaseThe Journal of Experimental Medicine, 1997
- Treatment of Autoimmune Disease by Oral Tolerance to AutoantigensClinical Immunology and Immunopathology, 1996
- Inflammatory cytokines in the brain: Does the CNS shape immune responses?Immunology Today, 1994
- Published by American Association for the Advancement of Science (AAAS) ,1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10Journal of Neuroimmunology, 1993
- Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired toleranceJournal of Autoimmunity, 1992
- The T Lymphocyte In Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Acute experimental autoimmune encephalomyelitis in miceCellular Immunology, 1982